D-0194-2025 Class III Ongoing

Recalled by Akron Pharma, Inc. — Fairfield, NJ

FDA drug recall D-0194-2025 was initiated by Akron Pharma, Inc. on Dec 12, 2024 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID. The recall status is ongoing. Affected quantity: 6429 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 22, 2025
Initiation Date
Dec 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6429 bottles

Product description

Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .

Reason for recall

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Distribution pattern

Nationwide in the US

Code information

Lot #: KDT0124001, Exp 08/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0194-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0194-2025. Report a data issue: hello@regdatalab.com.